Literature DB >> 16094130

Jugular foramen schwannomas: diagnosis, management, and outcomes.

Matthew A Wilson1, Todd A Hillman, Richard H Wiggins, Clough Shelton.   

Abstract

OBJECTIVES/HYPOTHESIS: To describe the presentation, radiographic findings, and surgical management of seven patients who have been diagnosed and treated with jugular foramen schwannomas at the University of Utah. STUDY
DESIGN: Retrospective chart review.
METHODS: The charts of seven patients diagnosed with jugular foramen schwannomas were reviewed for presentation symptoms, radiographic findings, and physical examination findings. For the six who underwent surgical excision, the surgical procedure used, cranial nerve function results, audiometric results, perioperative complications, and other follow-up data are presented.
RESULTS: Seven patients were identified from ages 24 to 69 years. Six of the seven underwent surgical excision. Primary presentation symptoms included dizziness, hearing loss, dysphagia, diplopia, tongue paresis, and hoarseness. The choice of surgical approach was based on the size and location of the tumor. All patients had complete excision of their tumors. The nerve of origin included the glossopharyngeal, vagus, and spinal accessory nerves. Preoperative cranial nerve dysfunction continued postoperatively for lower cranial nerves but resolved in patients who were noted to have preoperative dysfunction of cranial nerve V and VI. The rate of new lower cranial nerve injury was 15% and was only seen in the cranial nerves that were determined to be the nerve of origin. In two cases, a temporary feeding tube was required. No recurrences have been noted to date.
CONCLUSIONS: Jugular foramen schwannomas can be successfully diagnosed preoperatively with computed tomography and magnetic resonance imaging. These tumors can be successfully managed with surgery and low morbidity.

Entities:  

Mesh:

Year:  2005        PMID: 16094130     DOI: 10.1097/01.mlg.0000172196.76865.a1

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

1.  Nonvascular lesions of the jugular foramen: the gruppo otologico experience.

Authors:  Mario Sanna; Giuseppe De Donato; Filippo Di Lella; Maurizio Falcioni; Nitin Aggrawal; Guglielmo Romano
Journal:  Skull Base       Date:  2009-01

2.  Long-term outcomes after surgical treatment of jugular foramen schwannoma.

Authors:  Masafumi Fukuda; Makoto Oishi; Akihiko Saito; Yukihiko Fujii
Journal:  Skull Base       Date:  2009-11

3.  Facial and lower cranial nerve function preservation in lateral approach for craniocervical schwannomas.

Authors:  ZhaoYan Wang; HongSai Chen; Qi Huang; ZhiHua Zhang; Jun Yang; Hao Wu
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-14       Impact factor: 2.503

4.  The jugular foramen schwannomas: review of the large surgical series.

Authors:  Bulent Bakar
Journal:  J Korean Neurosurg Soc       Date:  2008-11-30

5.  Surgical outcomes of lateral approach for jugular foramen schwannoma: postoperative facial nerve and lower cranial nerve functions.

Authors:  Yang-Sun Cho; Yoon Kyoung So; Kwan Park; Chung-Hwan Baek; Han-Sin Jeong; Sung Hwa Hong; Won-Ho Chung
Journal:  Neurosurg Rev       Date:  2008-09-09       Impact factor: 3.042

6.  Schwannoma originating from lower cranial nerves: report of 4 cases.

Authors:  Hirofumi Oyama; Akira Kito; Hideki Maki; Kenichi Hattori; Tomoyuki Noda; Kentaro Wada
Journal:  Nagoya J Med Sci       Date:  2012-02       Impact factor: 1.131

7.  Efficacy of the Suboccipital Paracondylar-Lateral Cervical Approach: The Series of 64 Jugular Foramen Tumors Along With Follow-Up Data.

Authors:  Xiangyu Wang; Jian Yuan; Dingyang Liu; Yuanyang Xie; Ming Wu; Qun Xiao; Chaoying Qin; Jun Su; Yu Zeng; Qing Liu
Journal:  Front Oncol       Date:  2021-10-14       Impact factor: 6.244

Review 8.  Imaging of cerebellopontine angle lesions: an update. Part 1: enhancing extra-axial lesions.

Authors:  Fabrice Bonneville; Julien Savatovsky; Jacques Chiras
Journal:  Eur Radiol       Date:  2007-06-12       Impact factor: 7.034

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.